Head-to-head dispatch
Curve vs T2D.com
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Curve (Try Curve LLC) is a telehealth platform selling compounded semaglutide and tirzepatide, prescribed by Beluga Health providers and dispensed by VialsRx — but its site would not load over HTTPS when we last looked.
Marked down on: Its HTTPS certificate configuration failed from a clean network on August 29, 2026 — the host offered no certificate on trycurve.co or on www.trycurve.co, though it still answered on port 80 — so a reader cannot open the site.
Desk Score
T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.
$999/mo (starting dose, compounded) sema · $999/mo (starting dose, compounded) tirz · Verified July 20, 2026
Marked down on: No pricing published on the public website — must register to see costs
Curve takes this head-to-head with the higher Desk Score, 72/100 (C) against 51/100 (C) for T2D.com. T2D.com still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Curve
72/100
C
T2D.com
51/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Curve | T2D.com |
|---|---|---|
| Semaglutide | Not listed on Curve's site | $999/mo (starting dose, compounded) |
| Tirzepatide | Not listed on Curve's site | $999/mo (starting dose, compounded) |
| Coverage | All 50 states | 1 state |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Compounded semaglutide or tirzepatide with flat per-dose pricing from a LegitScript-certified seller, once the site is reachable again. | Diabetic GLP-1 access. |
| Desk Score | 72/100C | 51/100C |
The verdict
Desk pick — CurveCurve takes this head-to-head with the higher Desk Score, 72/100 (C) against 51/100 (C) for T2D.com. T2D.com still holds its ground where its strengths line up with yours.
Choose Curve if…
Compounded semaglutide or tirzepatide with flat per-dose pricing from a LegitScript-certified seller, once the site is reachable again.
All 50 states
Choose T2D.com if…
Diabetic GLP-1 access.
$999/mo (starting dose, compounded) sema · $999/mo (starting dose, compounded) tirz · 1 state
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Curve · T2D.com.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Curve
- CoreAge Rx vs T2D.com
- Curve vs Ondra Health
- System Labs vs T2D.com
- Curve vs Invigor Medical
- Levity vs T2D.com
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.